Skip to content

Catherine Marin Deugarte, M.D.

NPI 1801963277ActiveIndividual· Obstetrics & Gynecology, Reproductive Endocrinology· Los Angeles, CA

Obstetrics & Gynecology, Reproductive Endocrinology (M.D.) in Los Angeles, California, licensed in MI, with an NPI issued in November 2006. Ferring Pharmaceuticals Inc. was the largest of 3 companies reporting payments in 2025, $182.28 in all, mostly food and beverage.

Overview

NPI1801963277
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedNov 29, 2006
Last updated in NPPESJul 31, 2015

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$182.28 · 7 payments from 3 companies
  • 2024$107.55 · 4 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Ferring Pharmaceuticals Inc.$95.564
Organon LLC$62.012
Coopersurgical, Inc.$24.711

What the 2025 payments were for

  • Food and Beverage$182.28 · 7 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Obstetrics & Gynecology, Reproductive Endocrinology providers in Los Angeles

All Obstetrics & Gynecology, Reproductive Endocrinology providers in California →